Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v3-EN
Language English English
Date Updated 2021-10-02 2021-09-24
Drug Identification Number 02141450 02141450
Brand name 20% PROSOL 20% PROSOL
Common or Proper name Amino Acid Injection 20% w/v Amino Acid Injection 20% w/v
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients VALINE TYROSINE L-ASPARTIC ACID SERINE GLUTAMIC ACID PROLINE ARGININE GLYCINE ALANINE TRYPTOPHAN DL-METHIONINE THREONINE PHENYLALANINE LEUCINE ISOLEUCINE HISTIDINE LYSINE VALINE TYROSINE L-ASPARTIC ACID SERINE GLUTAMIC ACID PROLINE ARGININE GLYCINE ALANINE TRYPTOPHAN DL-METHIONINE THREONINE PHENYLALANINE LEUCINE ISOLEUCINE HISTIDINE LYSINE
Strength(s) 1.44G 0.05G 0.6G 1.02G 1.02G 1.34G 1.96G 2.06G 2.76G 0.32G 0.76G 0.98G 1G 1.08G 1.08G 1.18G 1.35G 1.44G 0.05G 0.6G 1.02G 1.02G 1.34G 1.96G 2.06G 2.76G 0.32G 0.76G 0.98G 1G 1.08G 1.08G 1.18G 1.35G
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 2000mL (JB6186) 2000mL (JB6186)
ATC code B05BA B05BA
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-09-23 2021-09-23
Estimated end date 2021-10-01 2021-10-09
Actual end date 2021-10-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Baxter is experiencing supply constraints due to the shortage of Travasol 10% 3000mL (DIN 00872296). As a result this product has been placed on allocation at 100% of historical usage. Baxter is experiencing supply constraints due to the shortage of Travasol 10% 3000mL (DIN 00872296). As a result this product has been placed on allocation at 100% of historical usage.
Health Canada comments